Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Horizon Therapeutics Denmark ApS
APS
Dissolved
Advertising protection
CVR 43478060
Sundkrogsgade 21, 2100
København Ø
Business and other management consultancy activities
·
NACE 7020
Est. 2022 · 3 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
Horizon Therapeutics Denmark ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
0M
-1M
-1M
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
DKK thousands
Item
2024
2023
Gross profit
0
-30
Staff expenses
-0
-0
EBITDA
0
-30
Depreciation & amort.
-0
-0
EBIT
0
-30
Net financials
1
0
Profit before tax
1
-30
Tax
-0
-0
Net profit
1
-30
Balance sheet
DKK thousands
Item
2024
2023
Total assets
46
40
Equity
41
10
Long-term debt
0
30
Short-term debt
5
0
Total debt
5
30
Financial ratios
5-year trend
EBITDA margin (of gross profit)
0,0 %
This company
2023
2024
Equity ratio
89,1 %
This company
38,2 %
Market median
This company
Market median
133% above market
2023
2024
Return on equity
1,2 %
This company
18,4 %
Market median
This company
Market median
93% below market
2023
2024
Net profit margin (of gross profit)
>999 %
This company
2023
2024
Asset turnover (of gross profit)
0,00×
This company
2023
2024
Debt / equity
0,12×
This company
0,62×
Market median
This company
Market median
81% below market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-08-25 – 2023-12-31
View
PDF
More on Horizon Therapeutics Denmark ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
